[Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma].
Nishikori
Momoko
M
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016499:Radioimmunotherapy; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab